Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ambiotech Bio-Pulsed Exosome for Tinnitus and Hearing Loss
- Development stage
- Preclinical
- Lead developer
- Ascension Medical Biotechnology
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Administration
- Intravenous, Intranasal
01
Overview
Ambiotech (Ascension Medical Biotechnology) is developing a Bio-Pulsed Exosome therapy for the treatment of tinnitus and hearing loss. The therapy is based on the company's patented Bio-Pulsed technology, which activates stem cells to produce exosomes—extracellular vesicles that act as cell-to-cell messengers and deliver growth factors and anti-inflammatory agents. The mechanism of action involves supporting neural or cochlear repair and regeneration, though specific molecular targets have not been fully disclosed. Ambiotech's Bio-Pulsed technology adjusts stem cell activation methods to modify exosome gene profiles according to therapeutic needs, producing exosomes with high purity (up to 99.99%) for applications in regenerative medicine. The therapy is currently in the preclinical development stage.
- Other names
- Exosome for TinnitusExosome for Hearing LossBio-Pulsed Exosome therapyextracellular vesicle (EV)-based therapy
Beyond the preview
Go deeper on Ambiotech Bio-Pulsed Exosome for Tinnitus and Hearing Loss.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ambiotech Bio-Pulsed Exosome for Tinnitus and Hearing Loss.